![Beth Smith](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Beth Smith
Comptroller/Controller/Auditor bij
MACROGENICS, INC.
Vermogen: 59 048 $ op 30-06-2026
Profiel
Beth Smith currently works at MacroGenics, Inc. as Treasurer, CAO & Vice President-Controller since 2025.
Formerly, Ms. Smith worked at Human Genome Sciences, Inc. as Accounting Director.
Ms. Smith completed undergraduate education at Bucknell University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
MACROGENICS, INC. 0,02% | 15-02-2026 | 12.781 ( 0,02% ) | 59 048 $ | 30-06-2026 |
Actieve functies van Beth Smith
| Bedrijven | Functie | Begin |
|---|---|---|
| MACROGENICS, INC. | Comptroller/Controller/Auditor | 01-01-2013 |
Eerdere bekende functies van Beth Smith
| Bedrijven | Functie | Einde |
|---|---|---|
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Comptroller/Controller/Auditor | - |
Opleiding van Beth Smith
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
28
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Health Technology |
MacroGenics, Inc.
 MacroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes antibody-based therapeutics for the treatment of cancer | Health Technology |
Bucknell University
 Bucknell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kies MarketScreener 
